Correlation Between Krystal Biotech and Lyell Immunopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Krystal Biotech and Lyell Immunopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krystal Biotech and Lyell Immunopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Krystal Biotech and Lyell Immunopharma, you can compare the effects of market volatilities on Krystal Biotech and Lyell Immunopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krystal Biotech with a short position of Lyell Immunopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krystal Biotech and Lyell Immunopharma.

Diversification Opportunities for Krystal Biotech and Lyell Immunopharma

0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between Krystal and Lyell is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Krystal Biotech and Lyell Immunopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyell Immunopharma and Krystal Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krystal Biotech are associated (or correlated) with Lyell Immunopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyell Immunopharma has no effect on the direction of Krystal Biotech i.e., Krystal Biotech and Lyell Immunopharma go up and down completely randomly.

Pair Corralation between Krystal Biotech and Lyell Immunopharma

Given the investment horizon of 90 days Krystal Biotech is expected to generate 0.35 times more return on investment than Lyell Immunopharma. However, Krystal Biotech is 2.87 times less risky than Lyell Immunopharma. It trades about 0.17 of its potential returns per unit of risk. Lyell Immunopharma is currently generating about 0.03 per unit of risk. If you would invest  17,689  in Krystal Biotech on August 28, 2024 and sell it today you would earn a total of  1,963  from holding Krystal Biotech or generate 11.1% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Krystal Biotech  vs.  Lyell Immunopharma

 Performance 
       Timeline  
Krystal Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Krystal Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Krystal Biotech is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Lyell Immunopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lyell Immunopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Krystal Biotech and Lyell Immunopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Krystal Biotech and Lyell Immunopharma

The main advantage of trading using opposite Krystal Biotech and Lyell Immunopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krystal Biotech position performs unexpectedly, Lyell Immunopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyell Immunopharma will offset losses from the drop in Lyell Immunopharma's long position.
The idea behind Krystal Biotech and Lyell Immunopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments